Let's focus on what we can do!

By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Ataxia
  • >
  • US FDA grants orphan drug designation to BHV-0223 for spinocerebellar ataxia treatment – pharmabiz.com

US FDA grants orphan drug designation to BHV-0223 for spinocerebellar ataxia treatment – pharmabiz.com

Friday, 11 March, 2016

US FDA grants orphan drug designation to BHV-0223 for spinocerebellar ataxia treatment – pharmabiz.com

Ataxia is a complaint of loss of control of voluntary body movements and can involve unsteady gait, speech difficulties, and clumsiness, potentially progressing to the stage of difficulty with swallowing and breathing due to degenerative changes in the ...

Read More

Source:US FDA grants orphan drug designation to BHV-0223 for spinocerebellar ataxia treatment - pharmabiz.com

Categories :
  • Ataxia
  • Latest Headlines
  • Uncategorized
Socials :

Recent posts